Iovance Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of IOVA for the last quarter is 715.00 k USD, and it's 48.34% higher compared to the previous quarter. The net income of Q1 24 is -112.98 M USD.